These results establish HMGB1 as a key antilipolytic factor, expanding the current understanding of adipocyte regulatory networks and offering new insights into obesity-related cardiovascular diseases associated with dysregulated lipolysis [11,14]. This evidence concerns the gene HMGB1 and obesity due to melanocortin 4 receptor deficiency.